US-based pharmaceutical company AbbVie has reported the final analysis from the Phase III MIRASOL trial, which assessed its ...

AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits ...

Mirvetuximab soravtansine improved overall survival over chemotherapy in patients with FRα-positive, platinum-resistant ovarian cancer.

Elizabeth K. Lee, MD, a medical oncologist in the gynecologic oncology program at Dana-Farber, presented results from a phase ...

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

Two months after the last chemotherapy, Bianca Balti resumes her battle against cancer. Fresh from participating in the Milan ...

Jessica Wozniak thought that some of the symptoms of norovirus were lingering. They were signs of Stage 4 colon cancer.

Glioblastoma has long resisted treatment, but scientists may have found a breakthrough by leveraging the body's own ...

As Colorectal Cancer Awareness Month highlights the importance of early detection and advancements in treatment, according to ...

The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...

According to a new analysis of a population index, the use of oral contraceptives, aka birth control, and a greater number of ...